Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 14955 [2019-07275]

Download as PDF Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices Development Stage: Reduces vascular injury while using large-bore introducer sheaths in interventional cardiac procedures: Transcatheter aortic valve replacement Direct transthoracic access into the heart muscle for endografts Inventors: Dr. Robert Lederman (NHLBI), Dr. Ozgur Kocaturk (NHLBI), Dr. Adam Greenbaum (Henry Ford Hospital). Intellectual Property: HHS Reference No. E–759–2013/0; U.S Provisional Patent Application 61/890,961 filed October 15, 2013, International Patent Application PCT/US2014/060270 filed October 13, 2014, U.S. Patent Application 15/025,336 filed March 28, 2016, European Patent 3057646 validated in Switzerland, Germany, France, the United Kingdom, and Ireland. Licensing Contact: Michael Shmilovich, Esq., CLP; 301–435–5019; shmilovm@mail.nih.gov. Dated: April 4, 2019. Michael A. Shmilovich, Senior Licensing and Patenting Manager, National Heart, Lung, and Blood Institute, Office of Technology Transfer and Development. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on May 30–31, 2019. The topic for this meeting will be ‘‘Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research.’’ The meeting is open to the public. Individuals planning to attend the workshop should register at https:// www.scgcorp.com/dmiccworkshop2019 at least 7 days prior to the workshop. DATES: The meeting will be held on May 30, 2019 from 8:00 a.m. to 5:45 p.m. and on May 31, 2019 from 8:00 a.m. to 3:00 p.m. ADDRESSES: The meeting will be held at the National Institutes of Health, 9000 Rockville Pike, Building 60/Cloisters, Lecture Hall/Chapel, Bethesda, MD 20892. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be jbell on DSK30RV082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:18 Apr 11, 2019 Jkt 247001 inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Dated: April 1, 2019. Bruce Tibor Roberts, Executive Secretary, DMICC, Office of Scientific Program and Policy Analysis, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. An agenda for the DMICC meeting will be available by contacting Mark Dennis, The Scientific Consulting Group, Inc. (mdennis@scgcorp.com; please put ‘‘Agenda Request for DMICC T1D Meeting’’ in the subject line). For further information concerning this meeting, contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892– 2560, telephone: 301–496–6623; FAX: 301–480–6741; email: dmicc@ mail.nih.gov. [FR Doc. 2019–07275 Filed 4–11–19; 8:45 am] FOR FURTHER INFORMATION CONTACT: The DMICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising members of the Department of Health and Human Services and other federal agencies that support diabetes-related activities, facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for Committee members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The May 30–31, 2019 DMICC meeting will focus on ‘‘Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research.’’ Any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, there will not be time on the agenda for oral comments from members of the public. Members of the public who would like to receive email notification about future DMICC meetings should register for the listserv available on the DMICC website, www.diabetescommittee.gov. SUPPLEMENTARY INFORMATION: [FR Doc. 2019–07232 Filed 4–11–19; 8:45 am] 14955 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, June 3, 2019, 6:00 p.m. to June 4, 2019, 6:00 p.m., Hilton Washington/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 08852 which was published in the Federal Register on March 27, 2019, 84 FR 11548. This meeting notice is amended to change the meeting start time on June 3, 2019 from 6:00 p.m. to 4:00 p.m. The meeting is closed to the public. Dated: April 8, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–07249 Filed 4–11–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Cellular and Molecular Biology of Neurodegeneration Study Section. Date: June 10–11, 2019. E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Page 14955]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07275]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on May 30-31, 2019. The topic for this 
meeting will be ``Opportunities for Research Supported by the Special 
Statutory Funding Program for Type 1 Diabetes Research.'' The meeting 
is open to the public. Individuals planning to attend the workshop 
should register at https://www.scgcorp.com/dmiccworkshop2019 at least 7 
days prior to the workshop.

DATES: The meeting will be held on May 30, 2019 from 8:00 a.m. to 5:45 
p.m. and on May 31, 2019 from 8:00 a.m. to 3:00 p.m.

ADDRESSES: The meeting will be held at the National Institutes of 
Health, 9000 Rockville Pike, Building 60/Cloisters, Lecture Hall/
Chapel, Bethesda, MD 20892. In the interest of security, NIH has 
instituted stringent procedures for entrance onto the NIH campus. All 
visitor vehicles, including taxicabs, hotel, and airport shuttles will 
be inspected before being allowed on campus. Visitors will be asked to 
show one form of identification (for example, a government-issued photo 
ID, driver's license, or passport) and to state the purpose of their 
visit.

FOR FURTHER INFORMATION CONTACT: An agenda for the DMICC meeting will 
be available by contacting Mark Dennis, The Scientific Consulting 
Group, Inc. ([email protected]; please put ``Agenda Request for DMICC 
T1D Meeting'' in the subject line). For further information concerning 
this meeting, contact Dr. B. Tibor Roberts, Executive Secretary of the 
Diabetes Mellitus Interagency Coordinating Committee, National 
Institute of Diabetes and Digestive and Kidney Diseases, 31 Center 
Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, 
telephone: 301-496-6623; FAX: 301-480-6741; email: [email protected].

SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising 
members of the Department of Health and Human Services and other 
federal agencies that support diabetes-related activities, facilitates 
cooperation, communication, and collaboration on diabetes among 
government entities. DMICC meetings, held several times a year, provide 
an opportunity for Committee members to learn about and discuss current 
and future diabetes programs in DMICC member organizations and to 
identify opportunities for collaboration. The May 30-31, 2019 DMICC 
meeting will focus on ``Opportunities for Research Supported by the 
Special Statutory Funding Program for Type 1 Diabetes Research.''
    Any interested person may file written comments with the Committee 
by forwarding their statement to the contact person listed on this 
notice. The statement should include the name, address, telephone 
number and, when applicable, the business or professional affiliation 
of the interested person. Because of time constraints for the meeting, 
there will not be time on the agenda for oral comments from members of 
the public.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC website, www.diabetescommittee.gov.

    Dated: April 1, 2019.
Bruce Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2019-07275 Filed 4-11-19; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.